US7264965B2
(en)
|
1998-06-05 |
2007-09-04 |
Alexis Biotech Limited |
Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class I molecule and an attaching means
|
GB2339782A
(en)
*
|
1998-06-05 |
2000-02-09 |
Philip Michael Savage |
Chimeric protein complexes comprising HLA class I antigens
|
US7521197B2
(en)
|
1998-06-05 |
2009-04-21 |
Alexis Biotech Limited |
Method for producing cytotoxic T-cells
|
US20040209314A1
(en)
|
1999-09-06 |
2004-10-21 |
Institut National De La Sante Et De La Recherche Medicale France |
Means for detection and purification of CD8+ T lymphocyte populations specific to peptides presented in the context of HLA
|
FR2798128B1
(fr)
*
|
1999-09-06 |
2001-11-16 |
Inst Nat Sante Rech Med |
Moyens de detection et de purification de populations lymphocytaires t cd8+ specifiques de peptides presentes dans le contexte hla
|
US20040191260A1
(en)
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
JP2004503213A
(ja)
*
|
2000-03-27 |
2004-02-05 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
1本鎖クラスi主要組織適合性複合体、それをコードする構築物およびそれを生成する方法
|
US8022190B2
(en)
*
|
2001-06-19 |
2011-09-20 |
Technion Research & Development Foundation Ltd. |
Immuno-molecules containing viral proteins, compositions thereof and methods of using
|
US20110045005A1
(en)
|
2001-10-19 |
2011-02-24 |
Craig Crowley |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
US20090068178A1
(en)
*
|
2002-05-08 |
2009-03-12 |
Genentech, Inc. |
Compositions and Methods for the Treatment of Tumor of Hematopoietic Origin
|
US9809654B2
(en)
|
2002-09-27 |
2017-11-07 |
Vaccinex, Inc. |
Targeted CD1d molecules
|
WO2004039324A2
(en)
*
|
2002-10-28 |
2004-05-13 |
Genzyme Corporation |
Anti-hiv (sl9) compounds
|
CA2518237A1
(en)
*
|
2003-03-04 |
2004-09-16 |
Greenville Hospital System |
Antitumor agents comprising a targeting portion and an immune response triggering portion
|
US20040210037A1
(en)
*
|
2003-03-28 |
2004-10-21 |
Vaccinex, Inc. |
Targeted MHC class I alpha3 vaccine delivery systems
|
US20050042218A1
(en)
*
|
2003-07-10 |
2005-02-24 |
Vaccinex, Inc. |
MHC class I - peptide-antibody conjugates with modified beta2-microglobulin
|
US9090673B2
(en)
*
|
2003-12-12 |
2015-07-28 |
City Of Hope |
Synthetic conjugate of CpG DNA and T-help/CTL peptide
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
KR101270829B1
(ko)
*
|
2004-09-23 |
2013-06-07 |
제넨테크, 인크. |
시스테인 유전자조작 항체 및 접합체
|
US20090061478A1
(en)
*
|
2006-01-30 |
2009-03-05 |
Lene Have Poulsen |
High-Speed Quantification of Antigen Specific T-Cells in Whole Blood by Flow Cytometry
|
AU2007243946B2
(en)
|
2006-04-05 |
2012-11-29 |
Curis, Inc. |
Method for using BOC/CDO to modulate hedgehog signaling
|
ES2549128T3
(es)
*
|
2006-05-19 |
2015-10-23 |
Technion Research And Development Foundation Ltd. |
Proteínas de fusión, usos de las mismas y procesos para producir las mismas
|
GB2442048B
(en)
*
|
2006-07-25 |
2009-09-30 |
Proimmune Ltd |
Biotinylated MHC complexes and their uses
|
US8617531B2
(en)
*
|
2006-12-14 |
2013-12-31 |
Bolder Biotechnology, Inc. |
Methods of making proteins and peptides containing a single free cysteine
|
JP5357782B2
(ja)
*
|
2007-02-21 |
2013-12-04 |
バクシネックス インコーポレーティッド |
抗原負荷CD1d分子によるNKT細胞活性の調節
|
WO2008116468A2
(en)
|
2007-03-26 |
2008-10-02 |
Dako Denmark A/S |
Mhc peptide complexes and uses thereof in infectious diseases
|
EP3023436A1
(de)
|
2007-07-03 |
2016-05-25 |
Dako Denmark A/S |
Verbesserte verfahren zur herstellung, markierung und verwendung von mhc-multimeren
|
WO2009012256A1
(en)
*
|
2007-07-16 |
2009-01-22 |
Genentech, Inc. |
Humanized anti-cd79b antibodies and immunoconjugates and methods of use
|
CL2008002085A1
(es)
|
2007-07-16 |
2008-11-21 |
Genentech Inc |
Anticuerpo humanizado anti-cd79b/igbeta/b29; polinucleotido codificacnte, vector, celula huesped; metodo de fabricacion; inmunoconjugado; composicion farmaceutica; uso para tratar cancer; metodo in vitro para determinar presencia de cd79b, oinhibir crecimiento de celulas quqe expresa cd79b; ensayo in vitro para detectar celulas b
|
EP2197908A2
(de)
|
2007-09-27 |
2010-06-23 |
Dako Denmark A/S |
Mhc-multimere in tuberkulose-diagnostika, -impfstoff und therapeutika
|
MX2010003718A
(es)
*
|
2007-10-19 |
2010-04-21 |
Genentech Inc |
Anticuerpos anti-tenb2 producidos por ingenieria de cisteina y conjugados de farmaco y anticuerpo.
|
EP2244729B1
(de)
|
2008-01-18 |
2016-11-02 |
MedImmune, LLC |
Cystein-manipulierte antikörper zur stellenspezifischen konjugation
|
PL2247620T3
(pl)
|
2008-01-31 |
2017-08-31 |
Genentech, Inc. |
Przeciwciała anty-CD79B i immunokoniugaty i sposoby stosowania
|
US10968269B1
(en)
|
2008-02-28 |
2021-04-06 |
Agilent Technologies, Inc. |
MHC multimers in borrelia diagnostics and disease
|
WO2010009735A2
(en)
*
|
2008-07-23 |
2010-01-28 |
Dako Denmark A/S |
Combinatorial analysis and repair
|
GB0817244D0
(en)
*
|
2008-09-20 |
2008-10-29 |
Univ Cardiff |
Use of a protein kinase inhibitor to detect immune cells, such as T cells
|
US10369204B2
(en)
|
2008-10-02 |
2019-08-06 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
US11992518B2
(en)
|
2008-10-02 |
2024-05-28 |
Agilent Technologies, Inc. |
Molecular vaccines for infectious disease
|
JP2012514476A
(ja)
|
2009-01-08 |
2012-06-28 |
アルバート アインシュタイン カレッジ オブ メディシン オブ イェシバ ユニバーシティ,ア ディビジョン オブ イェシバ ユニバーシティ |
細胞壁結合セラミド様糖脂質による細菌ワクチンおよびその使用
|
WO2010106535A1
(en)
|
2009-03-15 |
2010-09-23 |
Technion Research And Development Foundation Ltd. |
Soluble hla complexes for use in disease diagnosis
|
WO2010120561A1
(en)
*
|
2009-04-01 |
2010-10-21 |
Genentech, Inc. |
Anti-fcrh5 antibodies and immunoconjugates and methods of use
|
CN102369218B
(zh)
|
2009-04-01 |
2014-07-16 |
霍夫曼-拉罗奇有限公司 |
抗-FcRH5抗体和免疫缀合物以及应用方法
|
JP5918129B2
(ja)
|
2009-06-22 |
2016-05-18 |
メディミューン,エルエルシー |
部位特異的共役のための操作されたFc領域
|
MX338694B
(es)
|
2009-11-30 |
2016-04-27 |
Genentech Inc |
Composiciones y metodos para el diagnostico y el tratamiento de tumores.
|
PE20130214A1
(es)
|
2010-02-23 |
2013-03-11 |
Genentech Inc |
Composiciones y metodos para el diagnostico y tratamiento de tumores
|
EP2566893A1
(de)
|
2010-05-03 |
2013-03-13 |
F. Hoffmann-La Roche AG |
Zusammensetzungen und verfahren zur diagnose und behandlung von tumoren
|
WO2011146568A1
(en)
|
2010-05-19 |
2011-11-24 |
Genentech, Inc. |
Predicting response to a her inhibitor
|
WO2011156328A1
(en)
|
2010-06-08 |
2011-12-15 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
KR102057356B1
(ko)
|
2012-02-27 |
2019-12-18 |
아뮤닉스 파마슈티컬스, 인크. |
Xten 콘주게이트 조성물 및 그의 제조 방법
|
US9371352B2
(en)
|
2013-02-08 |
2016-06-21 |
Vaccinex, Inc. |
Modified glycolipids and methods of making and using the same
|
AR096687A1
(es)
|
2013-06-24 |
2016-01-27 |
Genentech Inc |
Anticuerpos anti-fcrh5
|
BR122021025087B1
(pt)
|
2013-12-17 |
2023-04-04 |
Genentech, Inc |
Anticorpo anti-cd3, célula hospedeira procariótica, método de produção do anticorpo biespecífico, imunoconjugado, composição, uso do anticorpo biespecífico e kit
|
CN107108724A
(zh)
|
2014-09-12 |
2017-08-29 |
豪夫迈·罗氏有限公司 |
半胱氨酸改造抗体和缀合物
|
DK3262071T3
(da)
|
2014-09-23 |
2020-06-15 |
Hoffmann La Roche |
Fremgangsmåde til anvendelse af anti-CD79b-immunkonjugater
|
AU2016280102B2
(en)
|
2015-06-16 |
2022-06-16 |
Genentech, Inc. |
Humanized and affinity matured antibodies to FcRH5 and methods of use
|
MA44334A
(fr)
|
2015-10-29 |
2018-09-05 |
Novartis Ag |
Conjugués d'anticorps comprenant un agoniste du récepteur de type toll
|
TW202332461A
(zh)
*
|
2016-08-11 |
2023-08-16 |
荷蘭商凱特製藥歐洲公司 |
製造和使用可溶性主要組織相容性複合體(mhc)分子類之方法
|
US10294454B2
(en)
|
2016-08-24 |
2019-05-21 |
General Electric Company |
Methods and kits for cell activation
|
EP3719033A1
(de)
*
|
2019-04-02 |
2020-10-07 |
imusyn GmbH & Co. KG |
Stabilisiertes mhc i
|
WO2021007338A1
(en)
|
2019-07-08 |
2021-01-14 |
Imcare Biotech, Llc. |
Anti-serine protease inhibitor kazal (spik) antibodies, immunoconjugates, and methods of use
|
WO2021050217A1
(en)
|
2019-09-11 |
2021-03-18 |
Imcare Biotech, Llc. |
Epitopes of anti-serine protease inhibitor kazal (spik) antibodies
|
JP2023507120A
(ja)
|
2019-12-18 |
2023-02-21 |
テネオフォー, インコーポレイテッド |
Cd38に結合する重鎖抗体
|
WO2022271987A1
(en)
|
2021-06-23 |
2022-12-29 |
TeneoFour, Inc. |
Anti-cd38 antibodies and epitopes of same
|